(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 27.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Glaukos's revenue in 2025 is $383,481,000.On average, 8 Wall Street analysts forecast GKOS's revenue for 2025 to be $27,205,235,786, with the lowest GKOS revenue forecast at $27,092,383,851, and the highest GKOS revenue forecast at $27,384,271,563. On average, 8 Wall Street analysts forecast GKOS's revenue for 2026 to be $35,049,548,337, with the lowest GKOS revenue forecast at $33,825,147,267, and the highest GKOS revenue forecast at $37,232,653,465.
In 2027, GKOS is forecast to generate $42,802,843,965 in revenue, with the lowest revenue forecast at $37,159,115,863 and the highest revenue forecast at $49,226,070,645.